This relatively short chain length contributes to its stability and ease of administration compared to larger protein structures
It is the story of a gut hormone glucagon-like peptide-1, or GLP-1 discovered in a Copenhagen laboratory in the 1980s, that turns out to sit at the centre of a wider physiological network linking the small intestine to the brain, the immune system, the cardiovascular system, and the metabolic regulation of nearly every major organ
According to the National Library of Medicine, GLP-1 or Glucagon-like-peptide-1 are agonists known to be associated with a class of medications which are utilised to treat type 2 diabetes mellitus (T2DM) and obesity
DOI: 10.1186/s12890-024-02904-2 35
You deserve to feel strong, steady, and unstoppable!
Adipose tissue is inherently pro-inflammatory, so losing weight naturally lowers inflammatory markers